Benzinga | Sep 8, 2021 07:07AM EDT

ADMA Biologics Receives FDA Approval For VanRx Aseptic Fill-Finish Machine And Related Operations

Expected to Provide Improved Gross Margins, Enhanced Patient Supply Consistency, Accelerated Inventory Production Cycle Time and Increased Control and Visibility of Commercial Product Lot Releases



Additional Opportunity for Contract Manufacturing Filling Services and Capabilities to Third Parties